Cargando…

Development of membrane-insertable lipid scrambling peptides: A time-resolved small-angle neutron scattering study

Phospholipid transbilayer movement (flip-flop) in the plasma membrane is regulated by membrane proteins to maintain cell homeostasis and interact with other cells. The promotion of flip-flop by phospholipid scramblases causes the loss of membrane lipid asymmetry, which is involved in apoptosis, bloo...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakao, Hiroyuki, Kimura, Yusuke, Sakai, Ami, Ikeda, Keisuke, Nakano, Minoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Crystallographic Association 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980860/
https://www.ncbi.nlm.nih.gov/pubmed/33758768
http://dx.doi.org/10.1063/4.0000045
_version_ 1783667495854407680
author Nakao, Hiroyuki
Kimura, Yusuke
Sakai, Ami
Ikeda, Keisuke
Nakano, Minoru
author_facet Nakao, Hiroyuki
Kimura, Yusuke
Sakai, Ami
Ikeda, Keisuke
Nakano, Minoru
author_sort Nakao, Hiroyuki
collection PubMed
description Phospholipid transbilayer movement (flip-flop) in the plasma membrane is regulated by membrane proteins to maintain cell homeostasis and interact with other cells. The promotion of flip-flop by phospholipid scramblases causes the loss of membrane lipid asymmetry, which is involved in apoptosis, blood coagulation, and viral infection. Therefore, compounds that can artificially control flip-flop in the plasma membrane are of biological and medical interest. Here, we have developed lipid scrambling transmembrane peptides that can be inserted into the membrane. Time-resolved small-angle neutron scattering measurements revealed that the addition of peptides containing a glutamine residue at the center of the hydrophobic sequence to lipid vesicles induces the flip-flop of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine. Peptides without the glutamine residue had no effect on the flip-flop. Because the glutamine-containing peptides exhibited scramblase activity in monomeric form, the polar glutamine residue would be exposed to the hydrocarbon region of the membrane, perturbing the membrane and promoting the lipid flip-flop. These scrambling peptides would be valuable tools to regulate lipid flip-flop in the plasma membrane.
format Online
Article
Text
id pubmed-7980860
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Crystallographic Association
record_format MEDLINE/PubMed
spelling pubmed-79808602021-03-22 Development of membrane-insertable lipid scrambling peptides: A time-resolved small-angle neutron scattering study Nakao, Hiroyuki Kimura, Yusuke Sakai, Ami Ikeda, Keisuke Nakano, Minoru Struct Dyn ARTICLES Phospholipid transbilayer movement (flip-flop) in the plasma membrane is regulated by membrane proteins to maintain cell homeostasis and interact with other cells. The promotion of flip-flop by phospholipid scramblases causes the loss of membrane lipid asymmetry, which is involved in apoptosis, blood coagulation, and viral infection. Therefore, compounds that can artificially control flip-flop in the plasma membrane are of biological and medical interest. Here, we have developed lipid scrambling transmembrane peptides that can be inserted into the membrane. Time-resolved small-angle neutron scattering measurements revealed that the addition of peptides containing a glutamine residue at the center of the hydrophobic sequence to lipid vesicles induces the flip-flop of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine. Peptides without the glutamine residue had no effect on the flip-flop. Because the glutamine-containing peptides exhibited scramblase activity in monomeric form, the polar glutamine residue would be exposed to the hydrocarbon region of the membrane, perturbing the membrane and promoting the lipid flip-flop. These scrambling peptides would be valuable tools to regulate lipid flip-flop in the plasma membrane. American Crystallographic Association 2021-03-19 /pmc/articles/PMC7980860/ /pubmed/33758768 http://dx.doi.org/10.1063/4.0000045 Text en © 2021 Author(s). 2329-7778/2021/8(2)/024301/6 All article content, except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle ARTICLES
Nakao, Hiroyuki
Kimura, Yusuke
Sakai, Ami
Ikeda, Keisuke
Nakano, Minoru
Development of membrane-insertable lipid scrambling peptides: A time-resolved small-angle neutron scattering study
title Development of membrane-insertable lipid scrambling peptides: A time-resolved small-angle neutron scattering study
title_full Development of membrane-insertable lipid scrambling peptides: A time-resolved small-angle neutron scattering study
title_fullStr Development of membrane-insertable lipid scrambling peptides: A time-resolved small-angle neutron scattering study
title_full_unstemmed Development of membrane-insertable lipid scrambling peptides: A time-resolved small-angle neutron scattering study
title_short Development of membrane-insertable lipid scrambling peptides: A time-resolved small-angle neutron scattering study
title_sort development of membrane-insertable lipid scrambling peptides: a time-resolved small-angle neutron scattering study
topic ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980860/
https://www.ncbi.nlm.nih.gov/pubmed/33758768
http://dx.doi.org/10.1063/4.0000045
work_keys_str_mv AT nakaohiroyuki developmentofmembraneinsertablelipidscramblingpeptidesatimeresolvedsmallangleneutronscatteringstudy
AT kimurayusuke developmentofmembraneinsertablelipidscramblingpeptidesatimeresolvedsmallangleneutronscatteringstudy
AT sakaiami developmentofmembraneinsertablelipidscramblingpeptidesatimeresolvedsmallangleneutronscatteringstudy
AT ikedakeisuke developmentofmembraneinsertablelipidscramblingpeptidesatimeresolvedsmallangleneutronscatteringstudy
AT nakanominoru developmentofmembraneinsertablelipidscramblingpeptidesatimeresolvedsmallangleneutronscatteringstudy